Salmeterol + Fluticasone propionate 25/250mgc 120 actuations 1s

EVOFLO Salmeterol + Fluticasone propionate 25/250mgc 120 actuations 1s

Asthma (Reversible Obstructive Airways Disease)
Salmeterol + Fluticasone propionate (Evoflo?) is indicated in the regular treatment of asthma (reversible obstructive airways disease).

This may include:
Patients on effective maintenance doses of long-acting beta-agonists and inhaled corticosteroids.
Patients who are symptomatic on current inhaled corticosteroid therapy.
Patients on regular bronchodilator therapy who require inhaled corticosteroids.
Chronic Obstructive Pulmonary Disease (COPD)
Salmeterol + Fluticasone propionate (Evoflo?) is indicated for the regular treatment of chronic obstructive pulmonary disease (COPD) including chronic bronchitis and emphysema.

Place of Origin

Spain

Product Usage

Each single actuation provides Salmeterol xinafoate equivalent to 25mcg of salmeterol and 125mcg of fluticasone propionate

Ingredients

Each single actuation provides Salmeterol xinafoate equivalent to 25mcg of salmeterol and 250mcg of fluticasone propionate

Width

3.35

Height

20.5

Depth

5.2